ID NP2 [Human normal mesothelial cells] AC CVCL_F1ZN SY NP 2 RX PubMed=25188816; RX PubMed=37566084; CC Doubling time: ~162 hours (PubMed=37566084). CC Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977. CC Cell type: Mesothelial cell; CL=CL_0000077. ST Source(s): PubMed=25188816; PubMed=37566084 ST Amelogenin: X,Y ST CSF1PO: 12,14 ST D13S317: 8,11 ST D16S539: 11 ST D18S51: 14,16 ST D21S11: 28,31 ST D3S1358: 15 ST D5S818: 12,13 ST D7S820: 9,11 ST D8S1179: 12,14 ST FGA: 22,24 ST Penta D: 9,13 ST Penta E: 11,16 ST TPOX: 8 ST vWA: 14,16 OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Sex unspecified AG Age unspecified CA Finite cell line DT Created: 31-03-26; Last updated: 31-03-26; Version: 1 CH CVCL_F1ZI ! NP2-hTERT+ // RX PubMed=25188816; DOI=10.1164/rccm.201404-0658OC; RA Schelch, Karin RA Hoda, Mir A. RA Klikovits, Thomas RA Munzker, Julia RA Ghanim, Bahil RA Wagner, Christina RA Garay, Tamas RA Laszlo, Viktoria RA Setinek, Ulrike RA Dome, Balazs RA Filipits, Martin RA Pirker, Christine RA Heffeter, Petra RA Selzer, Edgar RA Tovari, Jozsef RA Torok, Szilvia RA Kenessey, Istvan RA Holzmann, Klaus RA Grasl-Kraupp, Bettina RA Marian, Brigitte RA Klepetko, Walter RA Berger, Walter RA Hegedus, Balazs RA Grusch, Michael RT "Fibroblast growth factor receptor inhibition is active against RT mesothelioma and synergizes with radio- and chemotherapy."; RL Am. J. Respir. Crit. Care Med. 190:763-772(2014). // RX PubMed=37566084; DOI=10.3390/cells12152006; PMCID=PMC10417280; RA Ries, Alexander RA Slany, Astrid RA Pirker, Christine RA Mader, Johanna C. RA Mejri, Doris RA Mohr, Thomas RA Schelch, Karin RA Flehberger, Daniela RA Maach, Nadine RA Hashim, Muhammad RA Hoda, Mir Alireza RA Dome, Balazs RA Krupitza, Georg RA Berger, Walter RA Gerner, Christopher RA Holzmann, Klaus RA Grusch, Michael RT "Primary and hTERT-transduced mesothelioma-associated fibroblasts but RT not primary or hTERT-transduced mesothelial cells stimulate growth of RT Human Mesothelioma Cells."; RL Cells 12:2006-2006(2023). //